Drug intelligence / Profile preview

trifluoroacetonyl coenzyme a

Development stage: Unknown
Modality: Small Molecules

Overview

Trifluoroacetonyl coenzyme A is an experimental small molecule compound with the chemical formula C24H37F3N7O17P3S and an average molecular weight of 877.569. It is structurally related to acyl-CoA derivatives, in which the acyl group is replaced by a trifluoroacetone moiety. There are no approved indications or clinical trials for this compound, and its mechanism of action has not been described in available sources. The compound is listed as experimental and has not been approved for use in any country[1].

Other names: trifluoroacetonyl coenzyme a

Targets

CS (Chondroitin sulfate)

Beyond the preview

Go deeper on trifluoroacetonyl coenzyme a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on trifluoroacetonyl coenzyme a.

Explore the full profile